Roundup cancer lawsuits settled for over $10 billion

On Behalf of | Jul 6, 2020 | Commercial Litigation

Agrochemical giant Monsanto, maker of Roundup weed killer, has faced thousands of legal claims alleging that Roundup caused cancer, specifically non-Hodgkin lymphoma. Dallas business owners may be interested to learn that Bayer, Monsanto’s parent company, announced at the end of June that it has reached a settlement to these lawsuits for more than $10 billion.

According to the lawsuits, plaintiffs claimed Roundup is a carcinogenic and that Monsanto did not warn users of the product that it causes cancer. It was stated that an estimated 75% of the 125,000 filed and unfiled claims against Monsanto will be settled. Payments of $8.8 billion to $9.6 billion will be made to address existing claims, and $1.25 billion will be paid for potential future claims in a separate class action agreement. According to Bayer, this settlement does not mean it is admitting to being liable or that it committed any wrongful acts.

While thousands of legal claims involving Roundup were filed, only three claims were litigated. In all three of those cases, the court found that Roundup substantially contributed to the plaintiff’s cancer. Bayer plans on appealing those cases, as they are not included in the recent settlement.

When a company in the Dallas area is facing a major class action lawsuit or thousands of claims involving a single product, such claims are often settled without going to court. Settlements are often less costly for businesses, compared to a potential loss at trial. Of course, not every case can reach a settlement, and sometimes businesses will need to litigate a business dispute. Businesses facing a legal claim will want to explore all their legal options, whether that means settling the claim or taking the case to trial.